Table 2 Incidence and severity of CRBD, VAS

0 hr

0.5 hr

1 hr

4 hr

6 hr

0 hr

1 hr

2 hr

4 hr

6 hr

Incidence of CRBD (No.)

(%)

0 hr

0.0013*

0.5 hr

0.0001*

-No

26

(87)

27

(90)

27

(90)

26

(87)

26

(87)

20

(67)

19

(67)

18

(60)

17

(43)

16

(47)

1 hr

0.0001*

2 hr

0.0001*

-Yes

4

(13)

3

(10)

3

(10)

4

(13)

4

(13)

10

(33)

11

(33)

12

(40)

13

(57)

14

(53)

4 hr

0.0001*

6 hr

0.0001*

Severity of CRBD* (No.)

0 hr

0.5 hr

1 hr

2 hr

4 hr

6 hr

0 hr

0.5 hr

1 hr

2 hr

4 hr

6 hr

-Mild

2

2

2

2

3

2

2

4

4

5

5

6

Mild

Mod

Sev *

-Moderate

1

1

1

1

1

1

3

3

3

3

4

3

0 hr

1.000

0.08

0.0015

-Severe (No.) (%)

1

(3)

0

(0)

0

(0)

0

(0)

0

(0)

1

(3)

5

(17)

4

(13)

4

(13)

4

(13)

4

(13)

5

(17)

0.5 hr

0.238

0.08

0.0002

1 hr

0.238

0.08

0.0002

2 hr

0.04*

0.08

0.0002

4 hr

0.07

0.0165*

0.0002

6 hr

0.119

0.08

0.0015

VAS score (median)

10

20

20

20

10

10

20

40

40

40

30

30

No. of patients requiring fentanyl (%)

1

(3)

0

(0)

0

(0)

1

(3)

0

(0)

1

(3)

2

(7)

4

(13)

4

(13)

3

(10)

3

(10)

3

(10)

Total requirement of fentanyl (mcg) at the end of 6 hrs (mean+/− SD)

No. of patients requiring tramadol for CRBD management

2

(7)

1

(3)

1

(3)

1

(3)

1

(3)

2

(7)

8

(27)

7

(23)

7

(23)

7

(23)

8

(27)

8

(27)

Total requirement of tramadol (mg) at the end of 6 hrs (mean+/− SD)